Literature DB >> 22729459

Detection of pleural lymph flow using indocyanine green fluorescence imaging in non-small cell lung cancer surgery: a preliminary study.

Kazuhiro Imai1, Yoshihiro Minamiya, Hajime Saito, Taku Nakagawa, Manabu Ito, Takashi Ono, Satoru Motoyama, Yusuke Sato, Hayato Konno, Jun-ichi Ogawa.   

Abstract

PURPOSE: Lymphatic spread of lung carcinoma to the mediastinum is a key determinant of prognosis. The lymph flow often carries metastases from the pulmonary segment directly into the mediastinal lymph nodes, without passing through the hilar nodes. This phenomenon is termed as "skip metastasis." This study investigated the subpleural lymphatic flow to the mediastinum using indocyanine green (ICG) with a near-infrared fluorescence imaging system.
METHODS: Seventeen patients with lung cancer were enrolled in this study. A 0.3 ml sample of solution containing the fluorescent dye ICG (5 mg/ml) was injected into subpleural sites near the primary tumor. Fluorescence imaging was used to monitor the flow of ICG-containing lymph from the injection site for 5 min. The relationship between the anatomical segment of the primary tumor and the lymphatic flow was assessed.
RESULTS: The lymphatic vessels draining from the injection site were revealed by the bright ICG fluorescence in 14 of the patients (82.4 %). A direct lymphatic flow to the mediastinum was confirmed in 3 of those 14 (21.4 %).
CONCLUSIONS: These findings confirm the direct flow of lymph to the mediastinum without passage through the hilum pulmonis intraoperatively. These preliminary results may provide a valuable clue for further investigations of the mechanisms underlying skip metastasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729459     DOI: 10.1007/s00595-012-0237-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

1.  Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer.

Authors:  Toshiyuki Kitai; Takuya Inomoto; Mitsuharu Miwa; Takahiro Shikayama
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

2.  Intraoperative sentinel lymph node mapping using a new sterilizable magnetometer in patients with nonsmall cell lung cancer.

Authors:  Yoshihiro Minamiya; Manabu Ito; Yoshihisa Katayose; Hajime Saito; Kazuhiro Imai; Yusuke Sato; Jun-ichi Ogawa
Journal:  Ann Thorac Surg       Date:  2006-01       Impact factor: 4.330

Review 3.  Sentinel nodes in lung cancer: review of our 10-year experience.

Authors:  Hiroaki Nomori; Mitsutomo Kohno; Yotaro Izumi; Takashi Ohtsuka; Keisuke Asakura; Takashi Nakayama
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

4.  Anatomic basis of lymphatic spread from carcinoma of the lung to the mediastinum: surgical and prognostic implications.

Authors:  M Riquet
Journal:  Surg Radiol Anat       Date:  1993       Impact factor: 1.246

5.  Laparoscopic sentinel node navigation achieved by infrared ray electronic endoscopy system in patients with gastric cancer.

Authors:  K Ishikawa; K Yasuda; A Shiromizu; T Etoh; N Shiraishi; S Kitano
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 4.584

6.  Binding properties of indocyanine green in human blood.

Authors:  S Yoneya; T Saito; Y Komatsu; I Koyama; K Takahashi; J Duvoll-Young
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-06       Impact factor: 4.799

7.  Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.

Authors:  Klaus L Prenzel; Stephan E Baldus; Stefan P Mönig; Daniela Tack; Jan M Sinning; Christian A Gutschow; Guido Grass; Paul M Schneider; Hans P Dienes; Arnulf H Hölscher
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

8.  Skip mediastinal nodal metastases in non-small cell lung cancer.

Authors:  Fumihiro Tanaka; Kazumasa Takenaka; Hiroki Oyanagi; Takuji Fujinaga; Yosuke Otake; Kazuhiro Yanagihara; Harumi Ito; Hiromi Wada
Journal:  Eur J Cardiothorac Surg       Date:  2004-06       Impact factor: 4.191

9.  Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.

Authors:  Steven M Keller; Mark G Vangel; Henry Wagner; Joan H Schiller; Arnold Herskovic; Ritsuko Komaki; Randolph S Marks; Michael C Perry; Robert B Livingston; David H Johnson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

10.  A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer.

Authors:  Taku Nakagawa; Yoshihiro Minamiya; Yoshihisa Katayose; Hajime Saito; Kousei Taguchi; Hiroshi Imano; Hitoshi Watanabe; Katsuhiko Enomoto; Masato Sageshima; Tomoaki Ueda; Jun-ichi Ogawa
Journal:  J Thorac Cardiovasc Surg       Date:  2003-08       Impact factor: 5.209

View more
  12 in total

1.  Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients.

Authors:  Shinichiro Miyoshi; Kazuhiko Shien; Shinichi Toyooka; Kentaroh Miyoshi; Hiromasa Yamamoto; Seiichiro Sugimoto; Junichi Soh; Makio Hayama; Masaomi Yamane; Takahiro Oto
Journal:  Surg Today       Date:  2013-10-31       Impact factor: 2.549

2.  Is lower zone mediastinal nodal dissection always mandatory for lung cancer in the lower lobe?

Authors:  Hiroyasu Ueno; Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-01-27       Impact factor: 2.549

3.  Optimal settings and accuracy of indocyanine green fluorescence imaging for sentinel node biopsy in early gastric cancer.

Authors:  Shinichi Kinami; Toshio Oonishi; Jun Fujita; Yasuto Tomita; Hiroshi Funaki; Hideto Fujita; Yasuharu Nakano; Nobuhiko Ueda; Takeo Kosaka
Journal:  Oncol Lett       Date:  2016-04-25       Impact factor: 2.967

4.  Prognostic value of metastatic N1 lymph node ratio and angiolymphatic invasion in patients with pathologic stage IIA non-small cell lung cancer.

Authors:  Ching-Feng Wu; Ching-Yang Wu; Jui-Ying Fu; Chi-Wei Wang; Yun-Hen Liu; Ming-Ju Hsieh; Yi-Cheng Wu
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

5.  Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation.

Authors:  Chongwei Chi; Jinzuo Ye; Haolong Ding; De He; Wenhe Huang; Guo-Jun Zhang; Jie Tian
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

Review 6.  Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology.

Authors:  Chongwei Chi; Yang Du; Jinzuo Ye; Deqiang Kou; Jingdan Qiu; Jiandong Wang; Jie Tian; Xiaoyuan Chen
Journal:  Theranostics       Date:  2014-08-15       Impact factor: 11.556

7.  Risk factors of lobar lymph node metastases in non-primary tumor-bearing lobes among the patients of non-small-cell lung cancer.

Authors:  Jingwei Liu; Jian Li; Gang Lin; Zhiqiang Long; Qian Li; Bing Liu
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

8.  Electromagnetic navigation bronchoscopic localization versus percutaneous CT-guided localization for thoracoscopic resection of small pulmonary nodules.

Authors:  Yan-Long Yang; Zi-Zhe Li; Wei-Chao Huang; Jia Zhuang; Dai-Ying Lin; Wen-Zhao Zhong; Bin Lan
Journal:  Thorac Cancer       Date:  2021-01-04       Impact factor: 3.500

9.  Design and Testing of Augmented Reality-Based Fluorescence Imaging Goggle for Intraoperative Imaging-Guided Surgery.

Authors:  Seung Hyun Lee; Yu Hua Quan; Min Sub Kim; Ki Hyeok Kwon; Byeong Hyeon Choi; Hyun Koo Kim; Beop-Min Kim
Journal:  Diagnostics (Basel)       Date:  2021-05-21

10.  Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.

Authors:  Yue Yu; Renhong Huang; Pei Wang; Suyu Wang; Xinyu Ling; Peng Zhang; Jingwen Yu; Jun Wang; Jian Xiao; Zhinong Wang
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.